Azenta - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Azenta (AZTA) expands GENEWIZ with SynPlexity acquisition and $71m potential Elegen commitment

Bank of Montreal completes C$14.5bn equipment-finance portfolio sale to Stonepeak

Netanyahu’s Likud claims Israel election was stolen despite 53-seat result as officials reject fraud allegations

Cambrex has started construction on a $120 million expansion of its Charles City pharmaceutical manufacturing facility in Iowa, targeting additional active pharmaceutical ingredient and synthetic peptide production capacity by late 2028.

Cambrex begins $120m Iowa API expansion, but can new peptide capacity deliver commercial returns by 2028?

Read More

Pharma Industry News

Azenta (AZTA) expands GENEWIZ with SynPlexity acquisition and $71m potential Elegen commitment

Azenta, Inc. (NASDAQ: AZTA) has acquired synthetic biology specialist SynPlexity Inc. and entered an exclusive technology licensing arrangement…

byPallavi Madhiraju

October 30, 2026

Azenta, Inc. opens a new Genomics Laboratory in Oxford, UK, expanding its GENEWIZ Multiomics & Synthesis Solutions.

Read More

Healthcare Industry News

Azenta expands global reach with new genomics laboratory in Oxford, UK

Azenta, Inc. (Nasdaq: AZTA) announced the grand opening of its new Genomics Laboratory in Oxford, UK, marking a…

byPallavi Madhiraju

May 14, 2024

web analytics